Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PROGENITOR CELL PRODUCT INDUSTRY
2.1 Summary about Progenitor Cell Product Industry
2.2 Progenitor Cell Product Market Trends
2.2.1 Progenitor Cell Product Production & Consumption Trends
2.2.2 Progenitor Cell Product Demand Structure Trends
2.3 Progenitor Cell Product Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Pancreatic progenitor cells
4.2.2 Cardiac Progenitor Cells
4.2.3 Intermediate progenitor cells
4.2.4 Neural progenitor cells (NPCs)
4.2.5 Endothelial progenitor cells (EPC)
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Medical care
4.3.2 Hospital
4.3.3 Laboratory
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Pancreatic progenitor cells
5.2.2 Cardiac Progenitor Cells
5.2.3 Intermediate progenitor cells
5.2.4 Neural progenitor cells (NPCs)
5.2.5 Endothelial progenitor cells (EPC)
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Medical care
5.3.2 Hospital
5.3.3 Laboratory
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Pancreatic progenitor cells
6.2.2 Cardiac Progenitor Cells
6.2.3 Intermediate progenitor cells
6.2.4 Neural progenitor cells (NPCs)
6.2.5 Endothelial progenitor cells (EPC)
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Medical care
6.3.2 Hospital
6.3.3 Laboratory
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Pancreatic progenitor cells
7.2.2 Cardiac Progenitor Cells
7.2.3 Intermediate progenitor cells
7.2.4 Neural progenitor cells (NPCs)
7.2.5 Endothelial progenitor cells (EPC)
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Medical care
7.3.2 Hospital
7.3.3 Laboratory
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Pancreatic progenitor cells
8.2.2 Cardiac Progenitor Cells
8.2.3 Intermediate progenitor cells
8.2.4 Neural progenitor cells (NPCs)
8.2.5 Endothelial progenitor cells (EPC)
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Medical care
8.3.2 Hospital
8.3.3 Laboratory
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Pancreatic progenitor cells
9.2.2 Cardiac Progenitor Cells
9.2.3 Intermediate progenitor cells
9.2.4 Neural progenitor cells (NPCs)
9.2.5 Endothelial progenitor cells (EPC)
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Medical care
9.3.2 Hospital
9.3.3 Laboratory
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 NeuroNova AB
10.1.2 StemCells
10.1.3 ReNeuron Limited
10.1.4 Asterias Biotherapeutics
10.1.5 Thermo Fisher Scientific
10.1.6 STEMCELL Technologies
10.1.7 Axol Bio
10.1.8 R&D Systems
10.1.9 Lonza
10.1.10 ATCC
10.1.11 Irvine Scientific
10.1.12 CDI
10.2 Progenitor Cell Product Sales Date of Major Players (2017-2020e)
10.2.1 NeuroNova AB
10.2.2 StemCells
10.2.3 ReNeuron Limited
10.2.4 Asterias Biotherapeutics
10.2.5 Thermo Fisher Scientific
10.2.6 STEMCELL Technologies
10.2.7 Axol Bio
10.2.8 R&D Systems
10.2.9 Lonza
10.2.10 ATCC
10.2.11 Irvine Scientific
10.2.12 CDI
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
